Open AccessIn vitro activity of 79 antimicrobial agents against Corynebacterium group D2
Author(s) -
J.Á. García-Rodríguez,
José Elías García Sánchez,
Juan Luis Muñoz Bellido,
Teresa Nebreda-Mayoral,
E García Sánchez,
I. Garcia
Publication year - 1991
Publication title -
antimicrobial agents and chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.07
H-Index - 259
eISSN - 1070-6283
pISSN - 0066-4804
DOI - 10.1128/aac.35.10.2140
Subject(s) - teicoplanin , antimicrobial , microbiology and biotechnology , glycopeptide , vancomycin , antibiotics , ofloxacin , corynebacterium , doxycycline , biology , chemistry , staphylococcus aureus , bacteria , ciprofloxacin , genetics
Corynebacterium group D2 (CGD2) is involved in urinary tract infections in patients with underlying predisposing factors. This microorganism is highly resistant to a number of antimicrobial agents. We tested the activities of 79 antimicrobial agents against CGD2. beta-Lactams, aminoglycosides, and macrolides were ineffective. Fluorinated quinolones showed irregular activities, ofloxacin being the most active one. Doxycycline, rifampin, and mainly glycopeptides (vancomycin and teicoplanin) were the most active antibiotics against CGD2.